Related Experiment Video
Updated: May 6, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Homocysteine: cardiovascular risk factor in children and adolescents?
Adriana Amorim De Farias Leal1, Astrid Camêlo Palmeira, Gabriella Menezes Almeida De Castro
1Post-graduation Program in Public Health, Universidade Estadual da Paraíba, Campina Grande, PB, Brazil.
Insights
Homocysteine (He) is linked to cardiovascular diseases (CVD) in children and adolescents. Higher He levels correlate with older age and male gender, and lower vitamin levels, suggesting further research into pediatric hyperhomocysteinemia causes.
Area of Science:
- Pediatrics
- Cardiology
- Biochemistry
Background:
- Cardiovascular diseases (CVD) pose a significant health concern in pediatric populations.
- Understanding risk factors for CVD in children and adolescents is crucial for early intervention.
- Homocysteine (He) is a potential biomarker implicated in cardiovascular risk.
Purpose of the Study:
- To systematically review and identify literature investigating Homocysteine (He) as a risk factor for cardiovascular diseases (CVD) in pediatric populations (children and adolescents).
- To synthesize findings on the relationship between He levels and demographic or biochemical factors in this age group.
Main Methods:
- A comprehensive literature search was performed across multiple databases: LILACS, IBECS, Science Direct, Medline, and Cochrane Library.
- Keywords used included "homocysteine", "cardiovascular diseases", "child", and "adolescent".
- Fifteen relevant articles were selected and analyzed for their findings.
Main Results:
- A direct relationship was observed between higher Homocysteine (He) levels and increasing age (reported in 8 studies).
- Male gender was associated with higher He levels (reported in 10 studies).
- An inverse relationship was found between He levels and serum concentrations of vitamins B6, B12, and folate.
Conclusions:
- The findings suggest Homocysteine (He) may be a relevant factor in pediatric cardiovascular risk.
- Further research is warranted to elucidate the causes of hyperhomocysteinemia in the pediatric population.
- Dietary interventions focusing on nutrients essential for He metabolism may be beneficial.
Abstract:
The aim of this study was to identify publications in literature that investigated Homocysteine (He) as a risk factor for CVD among children and adolescents. An active search for information in LILACS, IBECS, Science Direct, Medline and Cochrane Library databases was conducted using the following combination of keywords "homocysteine", "cardiovascular diseases", "child" and "adolescent". Fifteen articles were analyzed showing direct relationship with increasing age (8 studies) and male gender (10 studies), and an inverse relationship with serum vitamins B6, B12 and folate levels. Thus, the results suggest that more research must be carried through in order to determine in a more coherent way the causes of the hiperhomocisteinemia in the pediatric population, guiding for an adequate diet, rich in nutrients necessary to favor the metabolism of the He.
More Related Videos
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
03:19Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes
Published on: June 28, 2024
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Lipids: Dietary Sources and Requirements
Coronary Artery Disease I: Introduction
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis III: Management